BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ho CT, Shang HS, Chang JB, Liu JJ, Liu TZ. Folate deficiency-triggered redox pathways confer drug resistance in hepatocellular carcinoma. Oncotarget. 2015;6:26104-26118. [PMID: 26327128 DOI: 10.18632/oncotarget.4422] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Wu W, Yang JL, Wang YL, Wang H, Yao M, Wang L, Gu JJ, Cai Y, Shi Y, Yao DF. Reversal of multidrug resistance of hepatocellular carcinoma cells by metformin through inhibiting NF-κB gene transcription. World J Hepatol 2016; 8(23): 985-993 [PMID: 27621764 DOI: 10.4254/wjh.v8.i23.985] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 3.3] [Reference Citation Analysis]
2 Shen PW, Ho CT, Hsiao SH, Chou YT, Chang YC, Liu JJ. Disruption of Cytosolic Folate Integrity Aggravates Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors and Modulates Metastatic Properties in Non-Small-Cell Lung Cancer Cells. Int J Mol Sci 2021;22:8838. [PMID: 34445544 DOI: 10.3390/ijms22168838] [Reference Citation Analysis]
3 Cui LH, Quan ZY, Piao JM, Zhang TT, Jiang MH, Shin MH, Choi JS. Plasma Folate and Vitamin B12 Levels in Patients with Hepatocellular Carcinoma. Int J Mol Sci 2016;17:E1032. [PMID: 27376276 DOI: 10.3390/ijms17071032] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
4 Su YH, Huang WC, Huang TH, Huang YJ, Sue YK, Huynh TT, Hsiao M, Liu TZ, Wu AT, Lin CM. Folate deficient tumor microenvironment promotes epithelial-to-mesenchymal transition and cancer stem-like phenotypes. Oncotarget 2016;7:33246-56. [PMID: 27119349 DOI: 10.18632/oncotarget.8910] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 4.4] [Reference Citation Analysis]
5 Wang M, Chen W, Chen J, Yuan S, Hu J, Han B, Huang Y, Zhou W. Abnormal saccharides affecting cancer multi-drug resistance (MDR) and the reversal strategies. Eur J Med Chem 2021;220:113487. [PMID: 33933752 DOI: 10.1016/j.ejmech.2021.113487] [Reference Citation Analysis]
6 Li C, Ni J, Liu YX, Wang H, Liang ZQ, Wang X. Response of MiRNA-22-3p and MiRNA-149-5p to Folate Deficiency and the Differential Regulation of MTHFR Expression in Normal and Cancerous Human Hepatocytes. PLoS One 2017;12:e0168049. [PMID: 28045918 DOI: 10.1371/journal.pone.0168049] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
7 Lai K, Chen C, Ho C, Liu J, Liu T, Chern C. Novel roles of folic acid as redox regulator: Modulation of reactive oxygen species sinker protein expression and maintenance of mitochondrial redox homeostasis on hepatocellular carcinoma. Tumour Biol 2017;39:101042831770264. [DOI: 10.1177/1010428317702649] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
8 Malaguarnera G, Catania VE, Latteri S, Borzì AM, Bertino G, Madeddu R, Drago F, Malaguarnera M. Folate levels in hepatocellular carcinoma patients with portal vein thrombosis. BMC Gastroenterol 2020;20:375. [PMID: 33172390 DOI: 10.1186/s12876-020-01525-3] [Reference Citation Analysis]